Brain Organoids Help Reveal Antiviral Drug's Promise in Parkinson's Disease
September 05, 2024
September 05, 2024
BETHESDA, Maryland, Sept. 5 (TNSres) -- The U.S. Department of Health and Human Services' National Center for Advancing Translational Sciences issued the following news on Sept. 4, 2024:
The antiviral drug tilorone may do more than just fight respiratory infections -- it might also help halt neural degeneration in Parkinson's disease (PD).
In a new study, NCATS scientists and their NIH colleagues tested tilorone's effects in models of the brain cells involved in PD. The . . .
The antiviral drug tilorone may do more than just fight respiratory infections -- it might also help halt neural degeneration in Parkinson's disease (PD).
In a new study, NCATS scientists and their NIH colleagues tested tilorone's effects in models of the brain cells involved in PD. The . . .